Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
33 pending office actions • 26 clients • 32 examiners • 23 art units • 0 of 33 (0%) have an AI response strategy ready • 37 patents granted in the last 365 days
HULTQUIST IP focuses its practice on the Biotechnology & Pharmaceuticals technology area. The firm has a significant history with 2992 career applications, reflecting a deep involvement in these specialized sectors. Its resolved allowance rate pct of 77.76 highlights its track record of securing patent grants for its clients. This metric indicates a steady capability for navigating the complex legal landscape of the life sciences.
The firm currently manages 25 pending office actions, indicating its ongoing workload. To achieve its grants, the firm navigates an avg office actions per allowance of 3.69. This figure indicates that applications often undergo multiple rounds of review and amendment before reaching an allowance. The 77.76 resolved allowance rate pct achieved across 2992 career applications suggests that the firm maintains a consistent approach to overcoming examiner rejections in the Biotechnology & Pharmaceuticals sector despite the 3.69 avg office actions per allowance. These data points provide a baseline for evaluating the firm's procedural expectations.
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 5 (15%) |
| §103 only | 6 (18%) |
| §102 only | 1 (3%) |
| §112 only | 3 (9%) |
| Double-patenting + other | 3 (9%) |
| Multi-statute (no §101) | 15 (45%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MIKNIS, ZACHARY J | 2 | 68.6% | +32.2% |
| NGUYEN, KATHLEEN V | 1 | 67.3% | +25.7% |
| AZUBUOGU, CHIEMERIE CHIBUZOR | 1 | 0.0% | +0.0% |
| MUKHOPADHYAY, BHASKAR | 1 | 28.2% | +37.0% |
| VISCONTI, GERALDINA | 1 | 86.5% | +1.5% |
| HELM, CARALYNNE E | 1 | 28.9% | +49.6% |
| PAK, YONG D | 1 | 74.6% | +14.3% |
| LAWRENCE JR, FRANK M | 1 | 83.9% | +19.8% |
| ROTONDI, CONNOR JON | 1 | 0.0% | +0.0% |
| STEELE, AMBER D | 1 | 58.9% | +9.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18829062 | STRUCTURES FOR PHYSICAL UNCLONABLE FUNCTION USING SPONTANEOUS CHIRAL SYMMETRY BREAKING AND METHOD OF PREPARING THE SAME | VISCONTI, GERALDINA | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18870358 | HAIR STYLING DEVICE | AZUBUOGU, CHIEMERIE CHIBUZOR | 10d overdue |
| 18822019 | Metal Oxide Compounds with Enhanced Reactivity | HELM, CARALYNNE E | 8d overdue |
| 18551590 | TARGET NUCLEIC ACID AMPLIFICATION METHOD USING GUIDE PROBE AND CLAMPING PROBE AND COMPOSITION FOR AMPLIFYING TARGET NUCLEIC ACID COMPRISING SAME | JONES, CHRISTINE MICHELLE | 27d |
| 18570202 | USE OF LACTOBACILLUS FERMENTUM STRAIN AND REGULATORY T CELLS FOR COMBINATION THERAPY FOR PREVENTION OR TREATMENT OF METABOLIC DISEASES | GORDON, MELENIE LEE | 41d |
| 18852449 | MEASURING DEVICE BASED ON A COMBINATION OF OPTICAL 2D AND 3D IMAGE CAPTURING METHODS | NGUYEN, KATHLEEN V | — |
| 18862545 | DEGRADATION-RESISTANT ALDEHYDE-CONTAINING COMPOSITIONS | MUKHOPADHYAY, BHASKAR | — |
| 18837131 | NOVEL LIPID PEROXIDATION SYSTEM AND METHOD FOR PREPARING BIOFUEL AND BIOPOLYMER USING SAME | PAK, YONG D | — |
| 18716787 | MATERIALS, SYSTEMS, AND PROCESSES FOR PRODUCTION OF HIGH PURITY OXYGEN | LAWRENCE JR, FRANK M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18822019 | Metal Oxide Compounds with Enhanced Reactivity | HELM, CARALYNNE E | 8d overdue |
| 18852449 | MEASURING DEVICE BASED ON A COMBINATION OF OPTICAL 2D AND 3D IMAGE CAPTURING METHODS | NGUYEN, KATHLEEN V | — |
| 18862545 | DEGRADATION-RESISTANT ALDEHYDE-CONTAINING COMPOSITIONS | MUKHOPADHYAY, BHASKAR | — |
| 18837131 | NOVEL LIPID PEROXIDATION SYSTEM AND METHOD FOR PREPARING BIOFUEL AND BIOPOLYMER USING SAME | PAK, YONG D | — |
| 18716787 | MATERIALS, SYSTEMS, AND PROCESSES FOR PRODUCTION OF HIGH PURITY OXYGEN | LAWRENCE JR, FRANK M | — |
| 18513613 | COMPOSITION FOR PREVENTING OR TREATING NON-ALCOHOLIC FATTY LIVER DISEASE OR NON-ALCOHOLIC STEATOHEPATITIS COMPRISING GROWTH DIFFERENTIATION FACTOR-15 VARIANT | MIKNIS, ZACHARY J | — |
| 18562322 | COMPOSITION FOR COMBINATION THERAPY COMPRISING GROWTH DIFFERENTIATION FACTOR-15 VARIANT AND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST | MIKNIS, ZACHARY J | — |
| Art Unit | Apps |
|---|---|
| 1653 | 2 |
| 3772 | 1 |
| 1737 | 1 |
| 1615 | 1 |
| 1779 | 1 |
| 2893 | 1 |
| 1617 | 1 |
| 1651 | 1 |
| 1658 | 1 |
| 1619 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18852449 | MEASURING DEVICE BASED ON A COMBINATION OF OPTICAL 2D AND 3D IMAGE CAPTURING METHODS | BESI Switzerland AG | NGUYEN, KATHLEEN V | §103§112 | Non-Final OA | — | Pending | May 09, 2025 | |
| 18870358 | HAIR STYLING DEVICE | Japham Group Limited | AZUBUOGU, CHIEMERIE CHIBUZOR | 3772 | §103§112Other | Non-Final OA | 10d overdue | Pending | Nov 27, 2024 |
| 18862545 | DEGRADATION-RESISTANT ALDEHYDE-CONTAINING COMPOSITIONS | Zoomessence, Inc. | MUKHOPADHYAY, BHASKAR | §103§112 | Non-Final OA | — | Pending | Nov 03, 2024 | |
| 18829062 | STRUCTURES FOR PHYSICAL UNCLONABLE FUNCTION USING SPONTANEOUS CHIRAL SYMMETRY BREAKING AND METHOD OF PREPARING THE SAME | Korea Advanced Institute Of Science And Technology | VISCONTI, GERALDINA | 1737 | §112 | Non-Final OA | — | Pending | Sep 09, 2024 |
| 18822019 | Metal Oxide Compounds with Enhanced Reactivity | Nanoionix, LLC | HELM, CARALYNNE E | 1615 | §102§103§112 | Non-Final OA | 8d overdue | Pending | Aug 30, 2024 |
| 18837131 | NOVEL LIPID PEROXIDATION SYSTEM AND METHOD FOR PREPARING BIOFUEL AND BIOPOLYMER USING SAME | Korea Advanced Institute Of Science And Technology | PAK, YONG D | §103§112 | Non-Final OA | — | Pending | Aug 08, 2024 | |
| 18716787 | MATERIALS, SYSTEMS, AND PROCESSES FOR PRODUCTION OF HIGH PURITY OXYGEN | Georgia Tech Research Corporation | LAWRENCE JR, FRANK M | §102§103§112 | Non-Final OA | — | Pending | Jun 05, 2024 | |
| 18681058 | PHOTOCATALYTIC PANEL REACTOR FOR THE ANAEROBIC PHOTOREFORMING OF WASTE AQUEOUS EFFLUENTS AND THE PRODUCTION OF HYDROGEN AS CO-PRODUCT | UNIVERSITAT ROVIRA I VIRGILI | ROTONDI, CONNOR JON | 1779 | §103 | Final Rejection | — | Pending | Feb 04, 2024 |
| 18580971 | COMPOSITION FOR PREVENTING OR TREATING LIVER DISEASES, COMPRISING STC-1 OR DERIVATIVE THEREOF | Industry-Academic Cooperation Foundation, Yonsei University | STEELE, AMBER D | §102§103§112 | Non-Final OA | — | Pending | Jan 19, 2024 | |
| 18577810 | SEMICONDUCTOR DEVICE STRUCTURE WITH RECESSED OHMIC CONTACTS AND METHOD FOR PRODUCING THE SAME | Swegan AB | CHEN, JACK S J | 2893 | §103§112 | Non-Final OA | — | Pending | Jan 09, 2024 |
| 18571238 | LIPID NANOPARTICLES AND METHOD FOR PREPARING SAME | Therna Therapeutics | PIPIC, ALMA | 1617 | §103§112 | Non-Final OA | — | Pending | Dec 17, 2023 |
| 18570202 | USE OF LACTOBACILLUS FERMENTUM STRAIN AND REGULATORY T CELLS FOR COMBINATION THERAPY FOR PREVENTION OR TREATMENT OF METABOLIC DISEASES | Gi Biome | GORDON, MELENIE LEE | 1651 | §102§103§112Other | Non-Final OA | 41d | Pending | Dec 14, 2023 |
| 18531541 | THERMAL ENERGY MEDIA WITH HIGH DURABILITY AND HIGH SOLAR ABSORPTIVITY AT HIGH TEMPERATURES | Advanced Materials Scientia LLC | DIAZ, MATTHEW R | §102§103§112 | Non-Final OA | — | Pending | Dec 06, 2023 | |
| 18567167 | NANOPARTICLE COMPRISING PEPTIDE-LIPID CONJUGATE FOR DELIVERING OLIGONUCLEOTIDE INTO TARGET CELL AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Seoul National University R&Db Foundation | SHIN, DANA H | §112 | Non-Final OA | — | Pending | Dec 05, 2023 | |
| 18513613 | COMPOSITION FOR PREVENTING OR TREATING NON-ALCOHOLIC FATTY LIVER DISEASE OR NON-ALCOHOLIC STEATOHEPATITIS COMPRISING GROWTH DIFFERENTIATION FACTOR-15 VARIANT | Yuhan Corporation | MIKNIS, ZACHARY J | §101§102§112DP | Non-Final OA | — | Pending | Nov 19, 2023 | |
| 18562322 | COMPOSITION FOR COMBINATION THERAPY COMPRISING GROWTH DIFFERENTIATION FACTOR-15 VARIANT AND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST | Yuhan Corporation | MIKNIS, ZACHARY J | 1658 | §101§102§112 | Non-Final OA | — | Pending | Nov 19, 2023 |
| 18513527 | BEVERAGE COMPOSITIONS FOR HYDRATION AND FOR SUPPORT OF HAIR HEALTH | Celmatrix Corporation | GREENE, IVAN A | 1619 | §102§103§112Other | Non-Final OA | — | Pending | Nov 18, 2023 |
| 18551590 | TARGET NUCLEIC ACID AMPLIFICATION METHOD USING GUIDE PROBE AND CLAMPING PROBE AND COMPOSITION FOR AMPLIFYING TARGET NUCLEIC ACID COMPRISING SAME | Hlb Panagene Co., Ltd. | JONES, CHRISTINE MICHELLE | 1682 | §102§103§112 | Final Rejection | 27d | Pending | Sep 20, 2023 |
| 18548539 | ELECTROLYTE SOLUTION FOR SECONDARY BATTERY, AND SECONDARY BATTERY COMPRISING SAME | Dongwha Electrolyte Co., Ltd. | DOMONE, CHRISTOPHER P | 1725 | §102 | Final Rejection | — | Pending | Aug 31, 2023 |
| 18262543 | PEPTIDE FOR PREVENTING AND TREATING FIBROSIS | Seoul National University R&Db Foundation | SCHWECHTER, BRANDON ROSS | 1674 | §102§112Other | Non-Final OA | — | Pending | Jul 21, 2023 |
| 18261882 | COMPOSITION FOR ALLEVIATING HAIR GRAYING, PROMOTING HAIR GROWTH AND/OR PREVENTING OR ALLEVIATING HAIR LOSS, COMPRISING DOUBLE-STRANDED MIRNA AS ACTIVE INGREDIENT | Sirnagen Therapeutics Corporation | YU, DAVID TUYANG | 1635 | §101§102§103§112 | Non-Final OA | — | Pending | Jul 18, 2023 |
| 18259375 | BI- OR MULTI-SPECIFIC ANTIBODY | Samsung Electronics | PETRASH, HILARY ANN | 1644 | §102§103§112DP | Non-Final OA | — | Pending | Jun 26, 2023 |
| 18251033 | METHOD FOR DETERMINING SENSITIVITY TO PARP INHIBITOR OR DNA DAMAGING AGENT USING NON-FUNCTIONAL TRANSCRIPTOME | Korea Advanced Institute Of Science And Technology | HOPPE, EMMA RUTH | 1683 | §112 | Final Rejection | 29d | Pending | Apr 28, 2023 |
| 18168613 | LOW-COST ENGINEERED PARTICLES FOR THERMAL ENERGY TRANSFER OR STORAGE | Advanced Materials Scientia LLC | WALKER, AJA ARYANNA | 1761 | §103§112DP | Non-Final OA | — | Pending | Feb 14, 2023 |
| 18164387 | DEEP LEARNING BASED METHOD FOR DIAGNOSING AND PREDICTING CANCER TYPE USING CHARACTERISTICS OF CELL-FREE NUCLEIC ACID | Gc Genome Corporation | LIN, JERRY | §101§102§112DP | Non-Final OA | — | Pending | Feb 03, 2023 | |
| 17907432 | COMPOSITION USING URINE SAMPLE FOR DIAGNOSIS OF KIDNEY DISEASE | Soonchunhyang University Industry Academy Cooperation Foundation | EVANS, CHRISTOPHER RYAN | 1677 | §101§103 | Non-Final OA | — | Pending | Sep 27, 2022 |
| 17759872 | COMPOSITION FOR TREATING CLIMACTERIC DISORDER COMPRISING LACTOBACILLUS GASSERI BNR17 | Acebiome Inc. | KOROTCHKINA, LIOUBOV G | 1653 | §103§112DP | Non-Final OA | — | Pending | Aug 01, 2022 |
| 17758573 | OXYGEN CARRIER PARTICLES HAVING METAL OXIDE-PEROVSKITE CORE-SHELL STRUCTURE AND CHEMICAL-LOOPING WATER/CARBON DIOXIDE THERMOCHEMICAL DECOMPOSITION PROCESS USING SAME | Korea Advanced Institute Of Science And Technology | CORALLO, CATRIONA MARY | 1732 | §103 | Final Rejection | — | Pending | Jul 09, 2022 |
| 17784970 | PRETREATMENT METHOD FOR UTILIZATION OF COAL ASH LANDFILLED IN ASH PONDS | National Institute Of Environmental Research | KUMAR, KALYANAVENKA K | 3653 | §103 | Non-Final OA | — | Pending | Jun 13, 2022 |
| 17692111 | NOVEL N-ACYLUREA DERIVATIVE AND COMPOSITION COMPRISING SAME FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASE | Kyungpook National University Industry- Academic Cooperation Foundation | AGUIRRE, AMANDA L | 1626 | §102§112 | Non-Final OA | — | Pending | Mar 10, 2022 |
| 17598199 | SPRAY-DRIED POWDERS | Zoomessence, Inc. | GWARTNEY, ELIZABETH A | 1759 | §103 | Final Rejection | 98d overdue | Pending | Sep 24, 2021 |
| 16759281 | COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES, CONTAINING MARINE FUNGUS PENICILLIUM SP. SF-5859-DERIVED CURVULARIN-TYPE METABOLITES | Korea Insititute Of Ocean Science And Technology | SIMMONS, CHRIS E | 1622 | §103 | Non-Final OA | — | Pending | Apr 24, 2020 |
| 14890585 | STEM CELL COMPOSITION FOR VENOUS ADMINISTRATION | Jeong-Chan Ra | MOSS, NATALIE M | 1653 | §103 | Final Rejection | 4d overdue | Pending | Nov 11, 2015 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial